N@N

Market Maker Surveillance Report. THC, WFC, XRX, ACTC, MITI, MCII, Highest Net Sell Volume and Negative Price Friction For Mon

February 6, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 3923 companies with "abnormal" market making, 2557 companies with positive Friction Factors and 3336 companies with negative Friction Factors. Here is a list of the top companies with the highest net sell volume on Monday and lowest negative price Friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. TENET HEALTHCARE CORP (NYSE:THC), WELLS FARGO & CO (NYSE:WFC), XEROX CORP (NYSE:XRX), ADVANCED CELL TECHNOLOGY INC (OTCBB:ACTC), Micromet Inc (NASDAQ:MITI), MARINER'S CHOICE INTERNATION (OTC:MCII). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     THC        $-0.030      -0.50%       3,154,983       20.17%       5,933,039       37.93%       -2,778,056      -926,019
     WFC        $-0.410      -1.34%       6,469,594       28.78%       8,764,183       38.99%       -2,294,589      -55,966 
     XRX        $-0.030      -0.38%       3,386,462       24.78%       6,367,220       46.60%       -2,980,758      -993,586
     ACTC       $-0.010      -8.26%       9,900,499       39.17%       15,377,513      60.83%       -5,477,014      -5,477,014
     MITI       $-0.010      -0.09%       2,469,325       29.28%       5,954,942       70.62%       -3,485,617      -3,485,617
     MCII       $-0.018      -48.00%      2,301,995       32.99%       4,676,525       67.01%       -2,374,530      -1,319,183

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have low price friction combined with more selling than buying (negative Net Volume) in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows THC down $-0.03000 with a Friction Factor of -926,019 and a Net Volume of -2,778,056. That means that it takes 926,019 more shares of selling than buying to drop THC by one penny. On Monday the Market Makers allowed the stock to move down on heavier selling than buying (low negative friction).

TENET HEALTHCARE CORP (NYSE:THC) - Tenet Healthcare Corporation, an investor-owned health care services company, operates general hospitals and related health care facilities. The companys general hospitals offer acute care services, radiology services, and respiratory therapy services, as well as operate operating and recovery rooms, and clinical laboratories and pharmacies. It also provides intensive care, critical care and/or coronary care units, and physical therapy; orthopedic, oncology, and outpatient services; tertiary care services, such as open-heart surgery, neonatal intensive care, and neuroscience; quaternary care in areas, including heart, lung, liver, and kidney transplants; gamma-knife brain surgery; cyberknife surgery for tumors and lesions in the brain, lung, neck, and spine; and bone marrow transplants. As of December 31, 2008, Tenet Healthcare Corporation operated 53 general hospitals; and a critical access hospital with a combined total of 14,352 licensed beds serving urban and rural communities. The company also operated various related health care facilities, including a rehabilitation hospital; a long-term acute care hospital; a skilled nursing facility; various medical office buildings; and physician practices, captive insurance companies, and other ancillary health care businesses, such as outpatient surgery centers, diagnostic imaging centers, and occupational and rural health care clinics, as well as owned interests in two health maintenance organizations. It has a joint venture agreement with MED3000 Inc. to provide services to physician practices. The company was founded in 1967 and is headquartered in Dallas, Texas with additional offices in Santa Ana, California; Coral Springs, Florida; and Philadelphia, Pennsylvania.

WELLS FARGO & CO (NYSE:WFC) - Wells Fargo & Company, through its subsidiaries, provides retail, commercial, and corporate banking services primarily in the United States. The company operates in three segments: Community Banking; Wholesale Banking; and Wealth, Brokerage, and Retirement. The Community Banking segment offers deposits, including checking, market rate, and individual retirement accounts; savings and time deposits; and debit cards. Its loan products comprise lines of credit, auto floor plans, equity lines and loans, equipment and transportation loans, education loans, residential mortgage loans, health savings accounts, and credit cards. This segment also provides equipment leases, real estate financing, small business administration financing, venture capital financing, cash management, payroll services, retirement plans, loans secured by autos, and merchant payment processing services; purchases sales finance contracts from retail merchants; and a family of funds, and investment management services. The Wholesale Banking segment offers commercial and corporate banking products and services, including commercial loans and lines of credit, letters of credit, asset-based lending, equipment leasing, international trade facilities, trade financing, collection services, foreign exchange services, treasury and investment management, institutional fixed-income sales, commodity and equity risk management, insurance, corporate trust fiduciary and agency services, and investment banking services. This segment also provides banking products for commercial real estate market, and real estate and mortgage brokerage services. The Wealth, Brokerage, and Retirement segment offers financial advisory, brokerage, and institutional retirement and trust services. As of December 31, 2010, the company served its customers through approximately 9,000 banking stores in 39 States and the District of Columbia. Wells Fargo & Company was founded in 1929 and is headquartered in San Francisco, California.

XEROX CORP (NYSE:XRX) - Xerox Corporation engages in the development, manufacture, marketing, service, and finance of document equipment, software, solutions, and services worldwide. The company operates in three segments: Technology, Services, and Other. The Technology segment provides multifunction printers, copiers, digital printing presses, light production devices, and desktop monochrome and color printers for office users. This segment also offers Extensible Interface Platform, a software platform that provides tools to create server based applications; and Xerox Mobile Print Solution, Xerox Mobile Express Driver, and Secure Access Unified ID System. The Services segment offers business process, information technology (IT), and document outsourcing services. Its business process outsourcing services include human resources, customer care, finance and accounting, healthcare payer and insurance, government services and solutions, transportation solutions, and card fare payment solutions. This segments IT outsourcing services comprise data center outsourcing, server outsourcing, network outsourcing, remote infrastructure management, help desk/service desk management, desktop outsourcing, managed storage, utility computing, disaster recovery, security, and IT commercial services. Its document outsourcing services include managed print services; consolidating in-house production and commercial printing; communication processes and back-office functions; designing, authoring, and translating technical documentation; and creating personalized and multi-channel marketing communications. The Other segment primarily sells paper, wide-format systems, and GIS network integration solutions and electronic presentation systems. The company sells its products and solutions through its sales force, as well as through a network of independent agents, dealers, value-added resellers, systems integrators, and the Web. Xerox Corporation was founded in 1906 and is headquartered in Norwalk, Connecticut.

ADVANCED CELL TECHNOLOGY INC (OTCBB:ACTC) - Advanced Cell Technology, Inc., a biotechnology company, focuses on the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine. It primarily focuses on cellular reprogramming, reduced complexity program, and stem cell differentiation research programs. The companys cellular reprogramming involves in the development of therapies based on the use of genetically identical pluripotent stem cells generated by its cellular reprogramming technologies. Advanced Cell Technology, Inc. is also generating stable cell lines with particular focus on blood lineage and vascular epithelial cell lines from hemangioblast cells. In addition, it is developing an autologous myoblast transplantation therapy to restore cardiac function in patients with advanced heart disease. The companys stem cell-based therapy would provide treatment for a range of acute and chronic degenerative diseases. Further, it develops adult stem cell-based products that are specifically targeted at therapies for heart and other cardiovascular diseases. The company is headquartered in Worcester, Massachusetts.

Micromet Inc (NASDAQ:MITI) - Micromet Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of antibodies for the treatment of cancer, inflammation, and autoimmune diseases. Its product development pipeline includes novel antibodies generated with its proprietary BiTE antibody platform, as well as conventional monoclonal antibodies. The companys lead product MT103 is in Phase II clinical trial for the treatment of acute lymphoblastic leukemia, as well as in Phase I trial for non-Hodgkins lymphoma. Its Phase II trial product also includes MT201 for solid tumors; and Phase I trial products comprise MT110 and MT293 for solid tumors, and MT203 for the treatment of inflammatory diseases. The companys products in preclinical stage include MT111 to treat solid tumors; BiTE antibody for acute myelogenic lymphoma and solid tumors; MT228 for melanoma; and MT204 for the treatment of inflammatory diseases, including rheumatoid arthritis, asthma, acute transplant rejection, uveitis, psoriasis, and multiple sclerosis. It has license agreements and collaborations with Biovation Limited; Enzon Pharmaceuticals, Inc.; MedImmune LLC; Bayer Schering Pharma AG; TRACON Pharmaceuticals, Inc.; Nycomed A/S; Morphotek, Inc.; Sanofi-Aventis; and Boehringer Ingelheim. The company is headquartered in Bethesda, Maryland.

MARINER'S CHOICE INTERNATION (OTC:MCII) - Mariners Choice International Inc. develops, manufactures, and markets products solutions using biodegradable technologies for the marine industry primarily in the United States. The company offers recreational and industrial solutions, including deck solutions for cleaning, maintaining, and sanitizing visible or aesthetic marine asset surfaces, such as hulls, decks, stainless steel, aluminum and other metal surfaces, canvas, vinyl, glass, counters, heads, boat bottoms, and carpets; under deck solutions comprising descaling and decalcification products for cleaning and maintaining bilge and holding tank systems; and personal care solutions consisting of solutions for the personal wellness of mariners and their guests and crew. It also offers marine fuel catalysts comprising diesel fuel enhancer, gasoline fuel enhancer, bunker fuel enhancer, and high performance 2-cycle oil alternative that protects valves, cylinders, and rings and lubricates crank seals. Mariners Choice International was founded in 1987 and is based in Jacksonville, Florida.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net